Literature DB >> 8250957

Common food additives are potent inhibitors of human liver 17 alpha-ethinyloestradiol and dopamine sulphotransferases.

K J Bamforth1, A L Jones, R C Roberts, M W Coughtrie.   

Abstract

Interactions between dietary xenobiotics, drugs and biologically active endogenous compounds are a potential source of idiosyncratic adverse pathology. We have examined the inhibition of the sulphation of a number of xenobiotics and endobiotics in human liver cytosol by 15 food additives and constituents. Sulphation of dehydroepiandrosterone was resistant to inhibition by all compounds tested; however, dopamine sulphotransferase (ST) activity was inhibited strongly by (+/-)-catechin, (+)-catechin, octyl gallate, tartrazine and vanillin. Sulphation of the xenobiotic steroid 17 alpha-ethinyloestradiol (EE2) was inhibited by vanillin, erythrosin B and octyl gallate. Of these compounds, only vanillin was found to be sulphated to a significant extent by both human liver and platelets, and vanillin was determined to be a substrate for the monoamine-sulphating isoenzyme of phenolsulphotransferase. Vanillin was found to inhibit 50% of liver EE2 ST activity (IC50) at a concentration of approximately 1.3 microM and the mode of inhibition was non-competitive. The implications of these results for the adverse side effects associated with food additives and oral contraceptives are discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8250957     DOI: 10.1016/0006-2952(93)90575-h

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  9 in total

1.  Reduced platelet phenolsulphotransferase activity towards dopamine and 5-hydroxytryptamine in migraine.

Authors:  A L Jones; R C Roberts; D W Colvin; G L Rubin; M W Coughtrie
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953

2.  Industrial, Biocide, and Cosmetic Chemical Inducers of Cholestasis.

Authors:  Vânia Vilas-Boas; Eva Gijbels; Axelle Cooreman; Raf Van Campenhout; Emma Gustafson; Kaat Leroy; Mathieu Vinken
Journal:  Chem Res Toxicol       Date:  2019-06-18       Impact factor: 3.739

3.  Pharmacogenetics of SULT1A1.

Authors:  Jaclyn Daniels; Susan Kadlubar
Journal:  Pharmacogenomics       Date:  2014-11       Impact factor: 2.533

4.  In Silico Prediction of Human Sulfotransferase 1E1 Activity Guided by Pharmacophores from Molecular Dynamics Simulations.

Authors:  Christin Rakers; Fabian Schumacher; Walter Meinl; Hansruedi Glatt; Burkhard Kleuser; Gerhard Wolber
Journal:  J Biol Chem       Date:  2015-11-05       Impact factor: 5.157

Review 5.  Hypothesis: holiday sudden cardiac death: food and alcohol inhibition of SULT1A enzymes as a precipitant.

Authors:  Ken Eagle
Journal:  J Appl Toxicol       Date:  2012-06-08       Impact factor: 3.446

Review 6.  Contribution of Biotransformations Carried Out by the Microbiota, Drug-Metabolizing Enzymes, and Transport Proteins to the Biological Activities of Phytochemicals Found in the Diet.

Authors:  Anna Boronat; Jose Rodriguez-Morató; Gabriele Serreli; Montserrat Fitó; Rachel F Tyndale; Monica Deiana; Rafael de la Torre
Journal:  Adv Nutr       Date:  2021-12-01       Impact factor: 11.567

Review 7.  Genetic and environmental factors associated with variation of human xenobiotic glucuronidation and sulfation.

Authors:  B Burchell; M W Coughtrie
Journal:  Environ Health Perspect       Date:  1997-06       Impact factor: 9.031

8.  Hepatic effects of tartrazine (E 102) after systemic exposure are independent of oestrogen receptor interactions in the mouse.

Authors:  Stephanie K Meyer; Philip M E Probert; Anne F Lakey; Andrew R Axon; Alistair C Leitch; Faith M Williams; Paul A Jowsey; Peter G Blain; George E N Kass; Matthew C Wright
Journal:  Toxicol Lett       Date:  2017-03-27       Impact factor: 4.372

9.  Toxicity of xanthene food dyes by inhibition of human drug-metabolizing enzymes in a noncompetitive manner.

Authors:  Takaharu Mizutani
Journal:  J Environ Public Health       Date:  2009-08-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.